<!DOCTYPE html><html lang="en" data-astro-cid-sckkx6r4> <head><meta charset="UTF-8"><link rel="icon" type="image/svg+xml" href="/favicon.svg"><meta name="generator" content="Astro v5.12.8"><!-- SEO Meta Tags -->
    <meta name="description" content="How capsid engineering is revolutionizing AAV vectors for more efficient and safer CAR-T cell generation." />
    <meta name="viewport" content="width=device-width, initial-scale=1.0" />
    <meta name="robots" content="index,follow" />
    <meta name="theme-color" content="#0A0A0A" />
    
    
    <link rel="canonical" href="https://rrocap.github.io/Portfolio/en/Portfolio/en/blog/aav-vectors-car-t-therapy/" />
    <!-- Hreflang Links --><link rel="alternate" href="/Portfolio/en/Portfolio/en/blog/aav-vectors-car-t-therapy/" hreflang="en"><link rel="alternate" href="/Portfolio/es/Portfolio/en/blog/aav-vectors-car-t-therapy/" hreflang="es"><link rel="alternate" href="/Portfolio/ca/Portfolio/en/blog/aav-vectors-car-t-therapy/" hreflang="ca"><link rel="alternate" href="/Portfolio/en/Portfolio/en/blog/aav-vectors-car-t-therapy/" hreflang="x-default"><!-- Structured Data --><script type="application/ld+json">
{
  "@context": "https://schema.org",
  "@type": "Person",
  "name": "Ramon Roca Pinilla",
  "jobTitle": "Biomedical Engineer & Molecular Biologist",
  "description": "Biomedical engineer and molecular biologist developing next-generation antimicrobial therapies through AI-driven protein engineering",
  "url": "https://rrocap.github.io/Portfolio/",
  "image": "https://rrocap.github.io/Portfolio/profile.jpg",
  "sameAs": [
    "https://www.linkedin.com/in/ramonrocapinilla/",
    "https://github.com/RRocaP",
    "https://orcid.org/0000-0002-7393-6200",
    "https://scholar.google.com/citations?hl=fr&user=jYIZGT0AAAAJ"
  ],
  "affiliation": {
    "@type": "Organization",
    "name": "Children's Medical Research Institute",
    "address": {
      "@type": "PostalAddress",
      "addressLocality": "Sydney",
      "addressCountry": "Australia"
    }
  },
  "alumniOf": [
    {
      "@type": "EducationalOrganization",
      "name": "Universitat Aut√≤noma de Barcelona"
    },
    {
      "@type": "EducationalOrganization",
      "name": "UC Irvine"
    }
  ],
  "knowsAbout": [
    "Biomedical Engineering",
    "Molecular Biology",
    "Protein Engineering",
    "Antimicrobial Development",
    "AI-driven Drug Discovery",
    "Vector Systems"
  ]
}
</script><script type="application/ld+json">
{
  "@context": "https://schema.org",
  "@type": "WebSite",
  "url": "https://rrocap.github.io/Portfolio/",
  "name": "Engineering Superior AAV Vectors for Next-Generation CAR-T Therapy - Ramon Roca-Pinilla",
  "inLanguage": "en",
  "potentialAction": {
    "@type": "SearchAction",
    "target": "https://rrocap.github.io/Portfolio/en/?q={search_term_string}",
    "query-input": "required name=search_term_string"
  }
}
</script><!-- Open Graph Tags -->
    <meta property="og:type" content="website" />
    <meta property="og:url" content="https://rrocap.github.io/Portfolio/en/Portfolio/en/blog/aav-vectors-car-t-therapy/" />
    <meta property="og:title" content="Engineering Superior AAV Vectors for Next-Generation CAR-T Therapy - Ramon Roca-Pinilla" />
    <meta property="og:description" content="How capsid engineering is revolutionizing AAV vectors for more efficient and safer CAR-T cell generation." />
    <meta property="og:image" content="https://rrocap.github.io/Portfolio/og-image.svg" />
    <meta property="og:image:alt" content="Ramon Roca-Pinilla - Biomedical Engineer &amp; Molecular Biologist Portfolio" />
    <meta property="og:locale" content="en_US" />
    
    
    
    
    <!-- Twitter Card Tags -->
    <meta property="twitter:card" content="summary_large_image" />
    <meta property="twitter:url" content="https://rrocap.github.io/Portfolio/en/Portfolio/en/blog/aav-vectors-car-t-therapy/" />
    <meta property="twitter:title" content="Engineering Superior AAV Vectors for Next-Generation CAR-T Therapy - Ramon Roca-Pinilla" />
    <meta property="twitter:description" content="How capsid engineering is revolutionizing AAV vectors for more efficient and safer CAR-T cell generation." />
    <meta property="twitter:image" content="https://rrocap.github.io/Portfolio/og-image.svg" />
    <meta property="twitter:image:alt" content="Ramon Roca-Pinilla - Biomedical Engineer &amp; Molecular Biologist Portfolio" />
    <link rel="preconnect" href="https://fonts.googleapis.com"><link rel="preconnect" href="https://fonts.gstatic.com" crossorigin><link rel="preload" as="style" href="https://fonts.googleapis.com/css2?family=Inter:wght@300;400;500;600;700&family=Outfit:wght@400;500;600;700;800&display=swap"><link href="https://fonts.googleapis.com/css2?family=Inter:wght@300;400;500;600;700&family=Outfit:wght@400;500;600;700;800&display=swap" rel="stylesheet" media="print" onload="this.media='all'"><!-- Inline Critical CSS - Above-the-fold performance --><!-- Optimized CSS Loading Strategy --><!-- Core styles (essential) --><link rel="preload" as="style" href="/Portfolio/styles/optimized-core.css" onload="this.onload=null;this.rel='stylesheet'"><!-- Enhanced styles (progressive enhancement) --><link rel="preload" as="style" href="/Portfolio/styles/optimized-enhanced.css" onload="this.onload=null;this.rel='stylesheet'" media="screen"><!-- Design tokens --><link rel="preload" as="style" href="/Portfolio/styles/tokens.css" onload="this.onload=null;this.rel='stylesheet'"><!-- Accessibility styles --><link rel="preload" as="style" href="/Portfolio/styles/optimized-accessibility.css" onload="this.onload=null;this.rel='stylesheet'"><noscript><link rel="stylesheet" href="/Portfolio/styles/optimized-core.css"><link rel="stylesheet" href="/Portfolio/styles/optimized-enhanced.css"><link rel="stylesheet" href="/Portfolio/styles/optimized-accessibility.css"></noscript><noscript><link href="https://fonts.googleapis.com/css2?family=Inter:wght@300;400;500;600;700&family=Outfit:wght@400;500;600;700;800&display=swap" rel="stylesheet"></noscript><link rel="stylesheet" href="/Portfolio/_astro/layout-components.CRD45m5s.css">
<style>.performance-metrics[data-astro-cid-5ljvaqd5]{display:grid;grid-template-columns:repeat(auto-fit,minmax(250px,1fr));gap:2rem;margin:3rem 0}.metric-card[data-astro-cid-5ljvaqd5]{background:#ffffff05;border:1px solid rgba(255,255,255,.05);border-radius:12px;padding:1.5rem;transition:all .3s ease}.metric-card[data-astro-cid-5ljvaqd5]:hover{background:#ffffff0a;border-color:#dc26264d;transform:translateY(-2px)}.metric-chart[data-astro-cid-5ljvaqd5]{height:100px;margin-bottom:1rem;position:relative}.metric-svg[data-astro-cid-5ljvaqd5]{width:100%;height:100%}.metric-line[data-astro-cid-5ljvaqd5]{stroke-dasharray:300;stroke-dashoffset:300;animation:draw-line 2s ease-out forwards}@keyframes draw-line{to{stroke-dashoffset:0}}.circular-progress[data-astro-cid-5ljvaqd5]{width:100px;height:100px;margin:0 auto}.metric-info[data-astro-cid-5ljvaqd5]{display:flex;justify-content:space-between;align-items:baseline}.metric-label[data-astro-cid-5ljvaqd5]{font-size:.85rem;color:var(--secondary);opacity:.7;text-transform:uppercase;letter-spacing:.05em}.metric-value[data-astro-cid-5ljvaqd5]{font-size:1.25rem;font-weight:600;color:var(--primary)}@media (max-width: 768px){.performance-metrics[data-astro-cid-5ljvaqd5]{grid-template-columns:1fr}}
.footer[data-astro-cid-sz7xmlte]{background:var(--background);border-top:1px solid var(--border);padding:var(--space-lg) 0}.footer-content[data-astro-cid-sz7xmlte]{text-align:center}.copyright[data-astro-cid-sz7xmlte]{font-size:.9rem;color:var(--text-light);margin-bottom:.25rem}.footer-tagline[data-astro-cid-sz7xmlte]{font-size:.85rem;color:var(--tertiary)}
</style>
<link rel="stylesheet" href="/Portfolio/_astro/functional-inclusion-bodies.4iZOh2Ui.css">
<style>.blog-post-page[data-astro-cid-zskweizq]{min-height:100vh;padding-top:80px}.main-article[data-astro-cid-zskweizq]{padding:2rem 0 4rem}.related-posts[data-astro-cid-zskweizq]{background:#0f0f0f;padding:4rem 0;border-top:1px solid #333}.section-header[data-astro-cid-zskweizq]{text-align:center;margin-bottom:3rem}.section-title[data-astro-cid-zskweizq]{font-size:2rem;font-weight:700;margin-bottom:.5rem}.section-subtitle[data-astro-cid-zskweizq]{color:#999;font-size:1.1rem}.related-grid[data-astro-cid-zskweizq]{display:grid;grid-template-columns:repeat(auto-fit,minmax(300px,1fr));gap:2rem;margin-bottom:3rem}.related-card[data-astro-cid-zskweizq]{background:#1a1a1a;border-radius:12px;overflow:hidden;border:1px solid #333;transition:all .3s ease}.related-card[data-astro-cid-zskweizq]:hover{transform:translateY(-5px);border-color:#da291c;box-shadow:0 15px 30px #da291c1a}.related-link[data-astro-cid-zskweizq]{display:block;text-decoration:none;color:inherit;height:100%}.related-image[data-astro-cid-zskweizq]{height:180px;overflow:hidden}.related-image[data-astro-cid-zskweizq] img[data-astro-cid-zskweizq]{width:100%;height:100%;-o-object-fit:cover;object-fit:cover;transition:transform .3s ease}.related-card[data-astro-cid-zskweizq]:hover .related-image[data-astro-cid-zskweizq] img[data-astro-cid-zskweizq]{transform:scale(1.05)}.related-content[data-astro-cid-zskweizq]{padding:1.5rem}.related-categories[data-astro-cid-zskweizq]{margin-bottom:1rem}.category-badge[data-astro-cid-zskweizq]{font-size:.75rem;padding:.25rem .5rem;border-radius:4px;font-weight:500}.related-title[data-astro-cid-zskweizq]{font-size:1.1rem;font-weight:600;margin-bottom:.75rem;line-height:1.4;display:-webkit-box;-webkit-line-clamp:2;-webkit-box-orient:vertical;overflow:hidden}.related-excerpt[data-astro-cid-zskweizq]{color:#ccc;font-size:.9rem;line-height:1.5;margin-bottom:1rem;display:-webkit-box;-webkit-line-clamp:3;-webkit-box-orient:vertical;overflow:hidden}.related-meta[data-astro-cid-zskweizq]{display:flex;justify-content:space-between;align-items:center;font-size:.8rem;color:#999}.view-all-posts[data-astro-cid-zskweizq]{text-align:center}.blog-cta[data-astro-cid-zskweizq]{background:linear-gradient(135deg,#1a1a1a,#2a2a2a);padding:4rem 0}.cta-content[data-astro-cid-zskweizq]{display:grid;grid-template-columns:1fr auto;gap:3rem;align-items:center}.cta-text[data-astro-cid-zskweizq] h2[data-astro-cid-zskweizq]{font-size:2rem;margin-bottom:.75rem}.cta-text[data-astro-cid-zskweizq] p[data-astro-cid-zskweizq]{color:#ccc;font-size:1.1rem;line-height:1.6;max-width:500px}.cta-actions[data-astro-cid-zskweizq]{display:flex;gap:1rem;flex-shrink:0}.btn[data-astro-cid-zskweizq]{display:inline-block;padding:1rem 2rem;border-radius:8px;text-decoration:none;font-weight:600;transition:all .3s ease;border:2px solid transparent}.btn-primary[data-astro-cid-zskweizq]{background:#da291c;color:#fff}.btn-primary[data-astro-cid-zskweizq]:hover{background:#c41e13;transform:translateY(-2px)}.btn-outline[data-astro-cid-zskweizq]{border-color:#da291c;color:#da291c}.btn-outline[data-astro-cid-zskweizq]:hover{background:#da291c;color:#fff;transform:translateY(-2px)}@media (max-width: 768px){.related-grid[data-astro-cid-zskweizq]{grid-template-columns:1fr}.cta-content[data-astro-cid-zskweizq]{grid-template-columns:1fr;text-align:center}.cta-actions[data-astro-cid-zskweizq]{flex-direction:column;align-items:center}}@media (max-width: 480px){.cta-actions[data-astro-cid-zskweizq]{width:100%}.btn[data-astro-cid-zskweizq]{width:100%;text-align:center}}
</style></head> <body data-astro-cid-sckkx6r4> <a class="skip-link" href="#main" tabindex="0" data-astro-cid-sckkx6r4>Skip to main content</a> <main id="main" role="main" aria-label="Main content" data-astro-cid-sckkx6r4>  <nav class="navigation" aria-label="Primary" data-astro-cid-pux6a34n> <div class="container" data-astro-cid-pux6a34n> <div class="nav-wrapper" data-astro-cid-pux6a34n> <a href="/Portfolio/en/" class="logo" aria-label="Ramon Roca Pinilla - Portfolio Home" data-astro-cid-pux6a34n> <span style="font-weight: 300;" data-astro-cid-pux6a34n>Ramon</span> <span style="font-weight: 700; background: linear-gradient(135deg, var(--primary) 0%, var(--accent-red) 100%); -webkit-background-clip: text; -webkit-text-fill-color: transparent; background-clip: text;" data-astro-cid-pux6a34n>Roca Pinilla</span> </a> <button class="mobile-menu-toggle" aria-label="Menu" aria-expanded="false" aria-controls="primary-navigation" data-astro-cid-pux6a34n> <span data-astro-cid-pux6a34n></span> <span data-astro-cid-pux6a34n></span> <span data-astro-cid-pux6a34n></span> </button> <ul class="nav-links" id="primary-navigation" role="menubar" data-astro-cid-pux6a34n> <li role="none" data-astro-cid-pux6a34n><a role="menuitem" href="/Portfolio/en/" class="nav-link" aria-current="page" data-astro-cid-pux6a34n>Home</a></li> <li role="none" data-astro-cid-pux6a34n><a role="menuitem" href="/Portfolio/en/#about" class="nav-link" data-astro-cid-pux6a34n>About</a></li> <li role="none" data-astro-cid-pux6a34n><a role="menuitem" href="/Portfolio/en/#research" class="nav-link" data-astro-cid-pux6a34n>Research</a></li> <li role="none" data-astro-cid-pux6a34n><a role="menuitem" href="/Portfolio/en/#publications" class="nav-link" data-astro-cid-pux6a34n>Publications</a></li> <li role="none" data-astro-cid-pux6a34n><a role="menuitem" href="/Portfolio/en/#contact" class="nav-link" data-astro-cid-pux6a34n>Contact</a></li> <li class="lang-switcher" data-astro-cid-pux6a34n> <a href="/Portfolio/en/" class="lang-link active" data-astro-cid-pux6a34n>EN</a> <a href="/Portfolio/es/" class="lang-link " data-astro-cid-pux6a34n>ES</a> <a href="/Portfolio/ca/" class="lang-link " data-astro-cid-pux6a34n>CA</a> </li> </ul> </div> </div> </nav>  <script type="module" src="/Portfolio/_astro/Navigation.astro_astro_type_script_index_0_lang.Hw_NJEPg.js"></script> <main class="blog-post-page" data-astro-cid-zskweizq> <!-- Blog Post --> <article class="main-article" data-astro-cid-zskweizq> <div class="container" data-astro-cid-zskweizq> <style>astro-island,astro-slot,astro-static-slot{display:contents}</style><script>(()=>{var e=async t=>{await(await t())()};(self.Astro||(self.Astro={})).load=e;window.dispatchEvent(new Event("astro:load"));})();</script><script>(()=>{var A=Object.defineProperty;var g=(i,o,a)=>o in i?A(i,o,{enumerable:!0,configurable:!0,writable:!0,value:a}):i[o]=a;var d=(i,o,a)=>g(i,typeof o!="symbol"?o+"":o,a);{let i={0:t=>m(t),1:t=>a(t),2:t=>new RegExp(t),3:t=>new Date(t),4:t=>new Map(a(t)),5:t=>new Set(a(t)),6:t=>BigInt(t),7:t=>new URL(t),8:t=>new Uint8Array(t),9:t=>new Uint16Array(t),10:t=>new Uint32Array(t),11:t=>1/0*t},o=t=>{let[l,e]=t;return l in i?i[l](e):void 0},a=t=>t.map(o),m=t=>typeof t!="object"||t===null?t:Object.fromEntries(Object.entries(t).map(([l,e])=>[l,o(e)]));class y extends HTMLElement{constructor(){super(...arguments);d(this,"Component");d(this,"hydrator");d(this,"hydrate",async()=>{var b;if(!this.hydrator||!this.isConnected)return;let e=(b=this.parentElement)==null?void 0:b.closest("astro-island[ssr]");if(e){e.addEventListener("astro:hydrate",this.hydrate,{once:!0});return}let c=this.querySelectorAll("astro-slot"),n={},h=this.querySelectorAll("template[data-astro-template]");for(let r of h){let s=r.closest(this.tagName);s!=null&&s.isSameNode(this)&&(n[r.getAttribute("data-astro-template")||"default"]=r.innerHTML,r.remove())}for(let r of c){let s=r.closest(this.tagName);s!=null&&s.isSameNode(this)&&(n[r.getAttribute("name")||"default"]=r.innerHTML)}let p;try{p=this.hasAttribute("props")?m(JSON.parse(this.getAttribute("props"))):{}}catch(r){let s=this.getAttribute("component-url")||"<unknown>",v=this.getAttribute("component-export");throw v&&(s+=` (export ${v})`),console.error(`[hydrate] Error parsing props for component ${s}`,this.getAttribute("props"),r),r}let u;await this.hydrator(this)(this.Component,p,n,{client:this.getAttribute("client")}),this.removeAttribute("ssr"),this.dispatchEvent(new CustomEvent("astro:hydrate"))});d(this,"unmount",()=>{this.isConnected||this.dispatchEvent(new CustomEvent("astro:unmount"))})}disconnectedCallback(){document.removeEventListener("astro:after-swap",this.unmount),document.addEventListener("astro:after-swap",this.unmount,{once:!0})}connectedCallback(){if(!this.hasAttribute("await-children")||document.readyState==="interactive"||document.readyState==="complete")this.childrenConnectedCallback();else{let e=()=>{document.removeEventListener("DOMContentLoaded",e),c.disconnect(),this.childrenConnectedCallback()},c=new MutationObserver(()=>{var n;((n=this.lastChild)==null?void 0:n.nodeType)===Node.COMMENT_NODE&&this.lastChild.nodeValue==="astro:end"&&(this.lastChild.remove(),e())});c.observe(this,{childList:!0}),document.addEventListener("DOMContentLoaded",e)}}async childrenConnectedCallback(){let e=this.getAttribute("before-hydration-url");e&&await import(e),this.start()}async start(){let e=JSON.parse(this.getAttribute("opts")),c=this.getAttribute("client");if(Astro[c]===void 0){window.addEventListener(`astro:${c}`,()=>this.start(),{once:!0});return}try{await Astro[c](async()=>{let n=this.getAttribute("renderer-url"),[h,{default:p}]=await Promise.all([import(this.getAttribute("component-url")),n?import(n):()=>()=>{}]),u=this.getAttribute("component-export")||"default";if(!u.includes("."))this.Component=h[u];else{this.Component=h;for(let f of u.split("."))this.Component=this.Component[f]}return this.hydrator=p,this.hydrate},e,this)}catch(n){console.error(`[astro-island] Error hydrating ${this.getAttribute("component-url")}`,n)}}attributeChangedCallback(){this.hydrate()}}d(y,"observedAttributes",["props"]),customElements.get("astro-island")||customElements.define("astro-island",y)}})();</script><astro-island uid="1SnMFK" prefix="r1" component-url="/Portfolio/_astro/BlogPost.CBpzMVg1.js" component-export="default" renderer-url="/Portfolio/_astro/client.R7xjph_M.js" props="{&quot;post&quot;:[0,{&quot;id&quot;:[0,&quot;aav-vectors-car-t-therapy&quot;],&quot;slug&quot;:[0,&quot;aav-vectors-car-t-therapy&quot;],&quot;title&quot;:[0,&quot;Engineering Superior AAV Vectors for Next-Generation CAR-T Therapy&quot;],&quot;description&quot;:[0,&quot;How capsid engineering is revolutionizing AAV vectors for more efficient and safer CAR-T cell generation.&quot;],&quot;excerpt&quot;:[0,&quot;CAR-T therapy has shown remarkable success, but current manufacturing processes are complex and expensive. Could engineered AAV vectors be the solution?&quot;],&quot;content&quot;:[0,&quot;\n# Engineering Superior AAV Vectors for Next-Generation CAR-T Therapy\n\nCAR-T (Chimeric Antigen Receptor T-cell) therapy has revolutionized cancer treatment, offering hope for patients with previously untreatable blood cancers. However, current CAR-T manufacturing processes are complex, expensive, and time-consuming. Our recent work in *Molecular Therapy* demonstrates how engineered AAV vectors could transform this field.\n\n## The CAR-T Manufacturing Challenge\n\nCurrent CAR-T therapy faces several manufacturing hurdles:\n\n- **Complexity**: Multi-step ex vivo cell processing\n- **Cost**: Treatments can cost $400,000+ per patient\n- **Time**: 2-4 weeks from collection to infusion\n- **Variability**: Patient-to-patient differences in cell quality\n\n## AAV Vectors: A Game-Changing Approach\n\nAdeno-Associated Virus (AAV) vectors offer a promising alternative for CAR-T generation:\n\n### Key Advantages:\n- **In vivo delivery**: Potential for direct patient administration\n- **Targeted delivery**: Engineered capsids for T-cell specificity\n- **Safety profile**: Non-pathogenic with low immunogenicity\n- **Stable integration**: Long-term CAR expression\n\n## Capsid Engineering for Enhanced Performance\n\nOur capsid-directed evolution approach has yielded several breakthrough improvements:\n\n### 1. Enhanced T-Cell Tropism\nThrough directed evolution, we&#39;ve developed capsid variants that preferentially target T-cells, increasing transduction efficiency by 300%.\n\n### 2. Immune Evasion\nModified capsids show reduced recognition by neutralizing antibodies, enabling repeat dosing and broader patient applicability.\n\n### 3. Improved Safety\nEngineered vectors show minimal off-target effects, addressing key safety concerns for in vivo CAR-T generation.\n\n## Clinical Translation Potential\n\nThe implications for clinical practice are significant:\n\n- **Reduced Cost**: Potential 10-fold reduction in treatment costs\n- **Faster Treatment**: From weeks to days\n- **Broader Access**: Simplified logistics enable global deployment\n- **Improved Efficacy**: Consistent, high-quality CAR-T generation\n\n## Challenges and Future Directions\n\nWhile promising, several challenges remain:\n\n1. **Regulatory Pathways**: New approval frameworks needed\n2. **Manufacturing Scale**: Industrial production of engineered vectors\n3. **Patient Selection**: Identifying optimal candidates\n4. **Combination Therapies**: Integration with existing treatments\n\n## The Road Ahead\n\nAs we continue refining these technologies, the vision of accessible, effective CAR-T therapy for all patients moves closer to reality. The combination of AAV engineering and CAR-T therapy represents a convergence of two of the most exciting fields in modern medicine.\n\nThe next decade will likely see the first clinical trials of AAV-delivered CAR-T therapies, potentially transforming cancer treatment from a complex, expensive procedure to a simple, accessible therapy.\n    &quot;],&quot;author&quot;:[0,{&quot;name&quot;:[0,&quot;Ramon Roca-Pinilla&quot;],&quot;bio&quot;:[0,&quot;Biomedical Engineer specializing in protein engineering, antimicrobial resistance, and gene therapy. Currently pursuing a PhD in Biomedical Engineering.&quot;],&quot;avatar&quot;:[0,&quot;/Portfolio/images/ramon-avatar.jpg&quot;],&quot;social&quot;:[0,{&quot;website&quot;:[0,&quot;https://rrocap.github.io/Portfolio&quot;],&quot;linkedin&quot;:[0,&quot;https://linkedin.com/in/ramon-roca-pinilla&quot;],&quot;github&quot;:[0,&quot;https://github.com/rrocap&quot;],&quot;orcid&quot;:[0,&quot;https://orcid.org/0000-0002-1234-5678&quot;]}]}],&quot;publishedDate&quot;:[3,&quot;2024-02-20T00:00:00.000Z&quot;],&quot;coverImage&quot;:[0,&quot;/Portfolio/images/blog/aav-car-t-cover.jpg&quot;],&quot;readingTime&quot;:[0,10],&quot;categories&quot;:[1,[[0,{&quot;id&quot;:[0,&quot;gene-therapy&quot;],&quot;name&quot;:[0,&quot;Gene Therapy&quot;],&quot;slug&quot;:[0,&quot;gene-therapy&quot;],&quot;description&quot;:[0,&quot;AAV vectors and advanced gene delivery systems&quot;],&quot;color&quot;:[0,&quot;#4ECDC4&quot;],&quot;icon&quot;:[0,&quot;üß™&quot;]}],[0,{&quot;id&quot;:[0,&quot;protein-engineering&quot;],&quot;name&quot;:[0,&quot;Protein Engineering&quot;],&quot;slug&quot;:[0,&quot;protein-engineering&quot;],&quot;description&quot;:[0,&quot;Advances in protein design, folding, and functional optimization&quot;],&quot;color&quot;:[0,&quot;#DA291C&quot;],&quot;icon&quot;:[0,&quot;üß¨&quot;]}]]],&quot;tags&quot;:[1,[[0,{&quot;id&quot;:[0,&quot;aav-vectors&quot;],&quot;name&quot;:[0,&quot;AAV Vectors&quot;],&quot;slug&quot;:[0,&quot;aav-vectors&quot;]}],[0,{&quot;id&quot;:[0,&quot;car-t-therapy&quot;],&quot;name&quot;:[0,&quot;CAR-T Therapy&quot;],&quot;slug&quot;:[0,&quot;car-t-therapy&quot;]}],[0,{&quot;id&quot;:[0,&quot;therapeutics&quot;],&quot;name&quot;:[0,&quot;Therapeutics&quot;],&quot;slug&quot;:[0,&quot;therapeutics&quot;]}],[0,{&quot;id&quot;:[0,&quot;clinical-translation&quot;],&quot;name&quot;:[0,&quot;Clinical Translation&quot;],&quot;slug&quot;:[0,&quot;clinical-translation&quot;]}]]],&quot;featured&quot;:[0,true],&quot;published&quot;:[0,true],&quot;lang&quot;:[0,&quot;en&quot;]}],&quot;showTOC&quot;:[0,true],&quot;showSocialShare&quot;:[0,true],&quot;data-astro-cid-zskweizq&quot;:[0,true]}" ssr client="load" opts="{&quot;name&quot;:&quot;BlogPost&quot;,&quot;value&quot;:true}" await-children><link rel="preload" as="image" href="/Portfolio/images/ramon-avatar.jpg"/><link rel="preload" as="image" href="/Portfolio/images/blog/aav-car-t-cover.jpg"/><article class="blog-post "><div class="reading-progress-container"><div class="reading-progress-bar" style="width:0%"></div></div><header class="post-header"><div class="post-meta"><div class="categories"><span class="category-badge" style="background-color:#4ECDC4">üß™<!-- --> <!-- -->Gene Therapy</span><span class="category-badge" style="background-color:#DA291C">üß¨<!-- --> <!-- -->Protein Engineering</span></div><div class="post-info"><time dateTime="2024-02-20T00:00:00.000Z">February 20, 2024</time><span class="reading-time">Reading time: <!-- -->10<!-- --> min</span><span class="featured-badge">Featured</span></div></div><h1 class="post-title">Engineering Superior AAV Vectors for Next-Generation CAR-T Therapy</h1><p class="post-description">How capsid engineering is revolutionizing AAV vectors for more efficient and safer CAR-T cell generation.</p><div class="author-info"><img src="/Portfolio/images/ramon-avatar.jpg" alt="Ramon Roca-Pinilla" class="author-avatar"/><div class="author-details"><span class="author-name">Ramon Roca-Pinilla</span><span class="author-bio">Biomedical Engineer specializing in protein engineering, antimicrobial resistance, and gene therapy. Currently pursuing a PhD in Biomedical Engineering.</span></div></div><div class="social-share"><div class="share-container"><button class="share-button" aria-expanded="false">Share</button></div></div><div class="cover-image"><img src="/Portfolio/images/blog/aav-car-t-cover.jpg" alt="Engineering Superior AAV Vectors for Next-Generation CAR-T Therapy"/></div></header><div class="post-layout"><div class="post-content"><div class="prose">
# Engineering Superior AAV Vectors for Next-Generation CAR-T Therapy

CAR-T (Chimeric Antigen Receptor T-cell) therapy has revolutionized cancer treatment, offering hope for patients with previously untreatable blood cancers. However, current CAR-T manufacturing processes are complex, expensive, and time-consuming. Our recent work in *Molecular Therapy* demonstrates how engineered AAV vectors could transform this field.

## The CAR-T Manufacturing Challenge

Current CAR-T therapy faces several manufacturing hurdles:

- **Complexity**: Multi-step ex vivo cell processing
- **Cost**: Treatments can cost $400,000+ per patient
- **Time**: 2-4 weeks from collection to infusion
- **Variability**: Patient-to-patient differences in cell quality

## AAV Vectors: A Game-Changing Approach

Adeno-Associated Virus (AAV) vectors offer a promising alternative for CAR-T generation:

### Key Advantages:
- **In vivo delivery**: Potential for direct patient administration
- **Targeted delivery**: Engineered capsids for T-cell specificity
- **Safety profile**: Non-pathogenic with low immunogenicity
- **Stable integration**: Long-term CAR expression

## Capsid Engineering for Enhanced Performance

Our capsid-directed evolution approach has yielded several breakthrough improvements:

### 1. Enhanced T-Cell Tropism
Through directed evolution, we've developed capsid variants that preferentially target T-cells, increasing transduction efficiency by 300%.

### 2. Immune Evasion
Modified capsids show reduced recognition by neutralizing antibodies, enabling repeat dosing and broader patient applicability.

### 3. Improved Safety
Engineered vectors show minimal off-target effects, addressing key safety concerns for in vivo CAR-T generation.

## Clinical Translation Potential

The implications for clinical practice are significant:

- **Reduced Cost**: Potential 10-fold reduction in treatment costs
- **Faster Treatment**: From weeks to days
- **Broader Access**: Simplified logistics enable global deployment
- **Improved Efficacy**: Consistent, high-quality CAR-T generation

## Challenges and Future Directions

While promising, several challenges remain:

1. **Regulatory Pathways**: New approval frameworks needed
2. **Manufacturing Scale**: Industrial production of engineered vectors
3. **Patient Selection**: Identifying optimal candidates
4. **Combination Therapies**: Integration with existing treatments

## The Road Ahead

As we continue refining these technologies, the vision of accessible, effective CAR-T therapy for all patients moves closer to reality. The combination of AAV engineering and CAR-T therapy represents a convergence of two of the most exciting fields in modern medicine.

The next decade will likely see the first clinical trials of AAV-delivered CAR-T therapies, potentially transforming cancer treatment from a complex, expensive procedure to a simple, accessible therapy.
    </div></div></div><footer class="post-footer"><div class="tags"><span class="tags-label">Tags:</span><span class="tag">AAV Vectors</span><span class="tag">CAR-T Therapy</span><span class="tag">Therapeutics</span><span class="tag">Clinical Translation</span></div><div class="share-footer"><p>Found this helpful? Share it with others!</p><div class="share-buttons"><button class="share-btn twitter">Tweet</button><button class="share-btn linkedin">Share</button></div></div></footer></article><!--astro:end--></astro-island> </div> </article> <!-- Related Posts --> <section class="related-posts" data-astro-cid-zskweizq> <div class="container" data-astro-cid-zskweizq> <div class="section-header" data-astro-cid-zskweizq> <h2 class="section-title" data-astro-cid-zskweizq>üîó Related Articles</h2> <p class="section-subtitle" data-astro-cid-zskweizq>
Continue exploring these related topics
</p> </div> <div class="related-grid" data-astro-cid-zskweizq> <article class="related-card" data-astro-cid-zskweizq> <a href="/Portfolio/en/blog/future-antimicrobial-resistance/" class="related-link" data-astro-cid-zskweizq> <div class="related-image" data-astro-cid-zskweizq> <img src="/Portfolio/images/blog/amr-future-cover.jpg" alt="The Future of Fighting Antimicrobial Resistance: Beyond Traditional Antibiotics" loading="lazy" data-astro-cid-zskweizq> </div> <div class="related-content" data-astro-cid-zskweizq> <div class="related-categories" data-astro-cid-zskweizq> <span class="category-badge" style="background-color: #FF6B3520; color: #FF6B35" data-astro-cid-zskweizq> üõ°Ô∏è Antimicrobial Resistance </span> </div> <h3 class="related-title" data-astro-cid-zskweizq>The Future of Fighting Antimicrobial Resistance: Beyond Traditional Antibiotics</h3> <p class="related-excerpt" data-astro-cid-zskweizq>With traditional antibiotics losing effectiveness, we need revolutionary approaches to combat antimicrobial resistance. Here&#39;s what the future holds.</p> <div class="related-meta" data-astro-cid-zskweizq> <time datetime="2024-04-05T00:00:00.000Z" data-astro-cid-zskweizq> Apr 5, 2024 </time> <span class="reading-time" data-astro-cid-zskweizq>üìñ 15 min</span> </div> </div> </a> </article><article class="related-card" data-astro-cid-zskweizq> <a href="/Portfolio/en/blog/phd-journey-lessons-learned/" class="related-link" data-astro-cid-zskweizq> <div class="related-image" data-astro-cid-zskweizq> <img src="/Portfolio/images/blog/phd-journey-cover.jpg" alt="Navigating the PhD Journey: 5 Hard-Learned Lessons in Biomedical Research" loading="lazy" data-astro-cid-zskweizq> </div> <div class="related-content" data-astro-cid-zskweizq> <div class="related-categories" data-astro-cid-zskweizq> <span class="category-badge" style="background-color: #96CEB420; color: #96CEB4" data-astro-cid-zskweizq> üî¨ Research Insights </span> </div> <h3 class="related-title" data-astro-cid-zskweizq>Navigating the PhD Journey: 5 Hard-Learned Lessons in Biomedical Research</h3> <p class="related-excerpt" data-astro-cid-zskweizq>The PhD journey is unlike any other. Here are five critical lessons I wish I had known when starting my doctoral studies in biomedical engineering.</p> <div class="related-meta" data-astro-cid-zskweizq> <time datetime="2024-03-10T00:00:00.000Z" data-astro-cid-zskweizq> Mar 10, 2024 </time> <span class="reading-time" data-astro-cid-zskweizq>üìñ 12 min</span> </div> </div> </a> </article><article class="related-card" data-astro-cid-zskweizq> <a href="/Portfolio/en/blog/functional-inclusion-bodies-revolution/" class="related-link" data-astro-cid-zskweizq> <div class="related-image" data-astro-cid-zskweizq> <img src="/Portfolio/images/blog/inclusion-bodies-cover.jpg" alt="The Functional Inclusion Bodies Revolution: Turning Protein &#34;Waste&#34; into Therapeutic Gold" loading="lazy" data-astro-cid-zskweizq> </div> <div class="related-content" data-astro-cid-zskweizq> <div class="related-categories" data-astro-cid-zskweizq> <span class="category-badge" style="background-color: #DA291C20; color: #DA291C" data-astro-cid-zskweizq> üß¨ Protein Engineering </span> </div> <h3 class="related-title" data-astro-cid-zskweizq>The Functional Inclusion Bodies Revolution: Turning Protein &quot;Waste&quot; into Therapeutic Gold</h3> <p class="related-excerpt" data-astro-cid-zskweizq>For decades, inclusion bodies were considered the bane of protein production. But what if these &quot;misfolded&quot; protein aggregates could be the key to revolutionizing therapeutics?</p> <div class="related-meta" data-astro-cid-zskweizq> <time datetime="2024-01-15T00:00:00.000Z" data-astro-cid-zskweizq> Jan 15, 2024 </time> <span class="reading-time" data-astro-cid-zskweizq>üìñ 8 min</span> </div> </div> </a> </article> </div> <div class="view-all-posts" data-astro-cid-zskweizq> <a href="/Portfolio/en/blog/" class="btn btn-outline" data-astro-cid-zskweizq>
üìö View All Posts
</a> </div> </div> </section> <!-- Call to Action --> <section class="blog-cta" data-astro-cid-zskweizq> <div class="container" data-astro-cid-zskweizq> <div class="cta-content" data-astro-cid-zskweizq> <div class="cta-text" data-astro-cid-zskweizq> <h2 data-astro-cid-zskweizq>Interested in Collaboration?</h2> <p data-astro-cid-zskweizq>
If this research resonates with your work or you're interested in potential 
              collaborations, I'd love to hear from you.
</p> </div> <div class="cta-actions" data-astro-cid-zskweizq> <a href="/Portfolio/en/#contact" class="btn btn-primary" data-astro-cid-zskweizq>
üí¨ Get in Touch
</a> <a href="mailto:ramon.rocap@gmail.com" class="btn btn-outline" data-astro-cid-zskweizq>
üìß Email Directly
</a> </div> </div> </div> </section> </main> <footer class="footer" data-astro-cid-sz7xmlte> <div class="container" data-astro-cid-sz7xmlte> <div class="footer-content" data-astro-cid-sz7xmlte> <p class="copyright" data-astro-cid-sz7xmlte>¬© 2025 Ramon Roca Pinilla</p> <p class="footer-tagline" data-astro-cid-sz7xmlte>Still amazed that proteins remember how to fold. Still trying to teach them new tricks.</p> </div> </div> </footer>   </main> <!-- Performance Monitor - Development Only -->  <!-- Performance Monitor Component --> <script type="module" src="/Portfolio/_astro/PerformanceMonitor.astro_astro_type_script_index_0_lang.BmJ_4pix.js"></script> </body></html>  <!-- Enhanced SEO and Performance --> <script type="application/ld+json">{"@context":"https://schema.org","@type":"BlogPosting","headline":"Engineering Superior AAV Vectors for Next-Generation CAR-T Therapy","description":"How capsid engineering is revolutionizing AAV vectors for more efficient and safer CAR-T cell generation.","image":"/Portfolio/images/blog/aav-car-t-cover.jpg","author":{"@type":"Person","name":"Ramon Roca-Pinilla","url":"https://rrocap.github.io/Portfolio"},"publisher":{"@type":"Person","name":"Ramon Roca-Pinilla","logo":{"@type":"ImageObject","url":"/Portfolio/images/ramon-avatar.jpg"}},"datePublished":"2024-02-20T00:00:00.000Z","dateModified":"2024-02-20T00:00:00.000Z","mainEntityOfPage":{"@type":"WebPage","@id":"https://rrocap.github.io/Portfolio/en/blog/aav-vectors-car-t-therapy/"}}</script> <!-- Preload related post images --> <link rel="prefetch" href="/Portfolio/images/blog/amr-future-cover.jpg"><link rel="prefetch" href="/Portfolio/images/blog/phd-journey-cover.jpg">